Citable company snapshot
Zimmer Biomet's latest SEC-sourced 2026-06-30 period shows $2.18B in revenue and $198.30M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $2.18B | $2.09B | +4.3% |
| Gross Profit | Dec 31, 2020 | $1.29B | $1.21B | +6.2% |
| Operating Income | Jun 30, 2026 | $326.10M | $373.20M | -12.6% |
| Net Income | Jun 30, 2026 | $198.30M | $238.10M | -16.7% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $447.80M | $359.40M | +24.6% |
| Free Cash Flow (computed) | Jun 30, 2026 | $393.60M | $323.10M | +21.8% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Aug 5, 2026; accession 0001193125-26-335044.
ZBH company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.